NASDAQ:SMMT
Summit Therapeutics Inc.
- Stock
locale
United Statesmarket
STOCKSindustry
Biotechnologywebsite
www.summittxinc.comipo date
Mar 05, 2015
Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecule antibiotic that is in Phase II...Show More
Earnings
Earnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus